Insight Molecular Diagnostics Inc. Debt Instrument, Decrease, Forgiveness
Insight Molecular Diagnostics Inc. (IMDX) reported Debt Instrument, Decrease, Forgiveness of $15.00 million for the 0-month period ending 2022-04-13, per its 10-Q filed 2022-11-10.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentDecreaseForgiveness · last filed 2022-11-10
- 2022-04-13: Debt Instrument, Decrease, Forgiveness 0 month $15.00M.
| Period end | Debt Instrument, Decrease, Forgiveness 0 month |
|---|---|
| 2022-04-13 | $15.00M 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |